There were no significant differences in age, sex, performance status, presence or absence of preceding MDS, cytogenetics, FLT-3 mutation status or FAB type expect for the presence of both PHLPP and PTEN, and PHLPP in the FAB5 group. The gene discussed is PHLPP1; the disease is myelodysplastic syndrome.